Imagine a country where depression, anxiety and post-traumatic stress are no longer suppressed with pills, but healed from within. Where psilocybin, the active ingredient in magic mushrooms, is recognised as medicine. That country exists: the Czech Republic.
At a time when mental health services are squeaking and creaking, the Czech Republic is making a revolutionary move. The country is on track to become the first European country to legalise psilocybin for medical use. And not only that: it is working on a pharmaceutical product, a synthetic psilocybin pill that doctors will soon be able to prescribe. A pharmaceutical first but fundamentally different from what we offer as a natural product.
From despair to hope
Jana Bednarova knows what it feels like to be trapped in depression. For twenty years she took antidepressants, to no avail. Until she was introduced to a microdose of magic truffles in the Netherlands four years ago. For the first time in years, she felt light. "Maybe I didn't have to die," she said.
This experience changed everything. Bednarova became a figurehead of Psyres, a Czech NGO that funds psilocybin research. Thanks to their efforts, there is now a bill recognising psilocybin as a medical drug. It was approved by the Chamber of Deputies at the end of May. It is now up to the Senate.
Psilocybin as therapy
The application of psilocybin in the clinic goes far beyond swallowing a capsule. Patients receive intensive counselling in safe, therapeutic environments. Sessions last a whole day, under the supervision of specialists. Music, eye masks, rest and integration are part of the process.
The results are impressive. Studies worldwide show that psilocybin can provide profound insights, emotional processing and lasting relief from therapy-resistant depression, anxiety, addiction and even Parkinson's disease.
"It is not a panacea," says Prof Pavel Mohr of the National Institute of Mental Health. "But it opens doors where conventional treatments fail."
From truffle to pill
What the Czech Republic is developing is a synthetic psilocybin pill. It contains a single isolated compound, detached from the complex biochemistry of the truffle. Unlike magic truffles, an all-natural product with dozens of active compounds, the pill lacks the entourage effect: the synergistic interplay of psilocin, baeocystin, norbaeocystin and other alkaloids jointly responsible for the gentle, gradual effect of microdosing.
Whereas the pill is aimed at clinical, short-term intervention, microdosing with truffles offers natural, slow and self-regulating support. Not an isolate but a living whole and readily available.
European focus
Although clinical studies are ongoing in many countries, including the Netherlands, Denmark and Portugal, the Czech Republic is now leading the way in legalisation. Political support is strong, with 68 per cent of the population supporting medical use of psychedelics.
According to Dr Tomas Palenicek of the Psyon Institute, psilocybin could be available to doctors by early 2026. However, a pharmaceutical product still needs to be developed, approved by the government and incorporated into the healthcare system.
What does this mean for the Netherlands?
In the Netherlands, magic truffles are already legally available. That means you can start microdosing today as a natural support for stress, gloom or lack of focus. Without pharma intervention, without chemical isolation.
And the beauty is: the difference is not just in the context, but in the content. Truffles are not a psilocybin capsule. They are a living entity, a symphony of connections that resonate together with your system. That is the power of the entourage effect.
Experience it yourself
At Microdosing XP, we believe in the power of nature. As the largest provider of magic truffles, we share the Czech Republic's vision: mental health deserves more than symptom relief. But where they isolate a molecule, we embrace the whole.
Find out how microdosing with magic truffles can also change your life. Read more about the science, experiences and applications via the link below: